Los Angeles Capital Management
CNST

Los Angeles Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Los Angeles Capital Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,220
Closed -$450K – 1736
2021
Q1 		$450K Sell
19,220
-21,437
-53% -$649K ﹤0.01% 1261
2020
Q4 		$1.17M Sell
40,657
-5,770
-12% -$145K 0.01% 867
2020
Q3 		$941K Buy
46,427
+7,300
+19% +$178K ﹤0.01% 844
2020
Q2 		$1.18M Buy
+39,127
New +$1.41M 0.01% 789

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Los Angeles Capital Management's CNST Position: Q2 2021 in Review

Los Angeles Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 19,220 shares — an estimated $450K sold.

Los Angeles Capital Management first reported a position in CNST in Q2 2020 and held it in 4 quarters. The position peaked at $1.18M in Q2 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Los Angeles Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 19,220 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $450K.
  • Los Angeles Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 4 quarters.
  • Los Angeles Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $1.18M in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.